SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
53 hedge funds and large institutions have $33.5M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 59 → 53 (-6)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
53
Holding in Top 10
1
Calls
$828K
Puts
$1K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$303K | |
| 3 | +$147K | |
| 4 |
BlackRock
New York
|
+$72.2K |
| 5 |
SC
Shay Capital
New York
|
+$38.8K |
Top Sellers
| 1 | -$665K | |
| 2 | -$206K | |
| 3 | -$81.6K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$57.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52.4K |